After 10,000% price hike, pharma companies face $350M+ fine in UK
After 10,000% price hike, pharma companies face $350M+ fine in UK esagonowsky Thu, 07/15/2021 - 09:47 Read the source article [...]
Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma’s July price hikes: report
Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma's July price hikes: report nhigginsdunn Thu, 07/15/2021 - [...]
Data shows voters strongly support protecting access to their medicines
In our current health care system, the Medicare Part D program helps ensure seniors and people with disabilities have access [...]
Republican Confidence In Science Drops Nearly 30 Points Since 1975, Poll Finds
As partisan debates continue about how urgent issues like the Covid-19 pandemic and climate change, a new survey finds Republicans [...]
Biogen, ICER experts tussle over Aduhelm as cost watchdogs unanimously slap down new Alzheimer’s drug
Biogen, ICER experts tussle over Aduhelm as cost watchdogs unanimously slap down new Alzheimer's drug nhigginsdunn Fri, 07/16/2021 - 01:30 [...]
Mental Health Economics and Public Mental Health Policy: Mental Health Services Costs, Quality and its Impact on Reducing the Burden of Mental Illness | Frontiers Research Topic
Mental disorders are burdensome, costly to society and cause negative outcomes at economic, social and health levels. The growing number [...]
Register Today for Upcoming ISPOR Short Course On Health Technology Assessments
ISPOR will hold a virtual short course on health technology assessments (HTAs) on July 20th and 21st at 8:00 AM [...]
RWD Powerhouse OM1 Announces $85 Million in Financing to Personalize Healthcare and Target Chronic Diseases
Real world data (RWD) company OM1 has announced $85 million in financing. The company uses RWD to develop personalized treatments [...]
21st Century Cures Version 2.0 Public Comment Deadline is Today
The comment period for the 21st Century Cures Version 2.0 is today, July 16th. You may send your feedback to [...]
Astellas US President Discusses Improving Medication Affordability, Patient-Centered Care, and Learning From COVID-19 Challenges
PhRMA board member and Astellas US President Mark Reisenauer shares his thoughts on improving the healthcare system in the United [...]
Why Are High-Impact Medical Journal Articles Authored by Women Cited Less Frequently than Those by Men?
A report published in JAMA Open Network by University of Pennsylvania’s Drs. Paula Chatterjee and Rachel Werner finds that articles [...]
Effective Value-Based Healthcare Requires Rejecting Inferior Approaches and Promoting Health Equity
Although many approaches to value-based healthcare have been proposed or implemented in recent years, not all of them adequately address [...]
ICER Proposes Legislative Mechanisms to Keep Prices Low for Drugs Receiving FDA’s Accelerated Approval Designation
The Institute for Clinical and Economic Review (ICER) suggests enacting federal legislation that would keep prices low for drugs receiving [...]
HEOR Article Notes Intricacies of Well-Being Valuation Approach to Quantitatively Determine Healthcare Value
A recent article, published in Health Economics, considers methods used to assess healthcare value and therapeutic cost-effectiveness. The researchers used [...]
Pelosi Seeks Prescription Drug Pricing Legislation Including Medicare Negotiation as House Report Notes Pharma Spent $577 Billion on Stock Buybacks and Dividends
House Speaker Nancy Pelosi announced she will push for drug pricing legislation to be included in President Biden’s economic budget, [...]
Aetion and Cegedim Health to Continue Rewarding RWD Partnership to Track Medication Efficacy and Safety
Aetion and Cegedim Health have announced that they will continue their real world data (RWD) partnership. The collaboration combines Aetion’s [...]
The Trillion Dollar Revolution by Ezekiel J. Emanuel
In March 2010, the Affordable Care Act officially became one of the seminal laws determining American health care. From day [...]
Good pharma citizenship is more than tree hugging. ESG needs drug pricing input, analysts say
Pharma environment and social goals need to include—the Institute for Clinical and Economic Review (ICER)? They should, one analyst firm [...]
Moving Beyond the Spreadsheet in Measuring Pharmacy Benefit Value
Many experts have stated that the prescription drug chain is complex and confusing. However, there seems to be a growing [...]
People: Ogilvy names prominent health industry leader Kim Johnson Global CEO of Ogilvy Health
NEW YORK, USA — Ogilvy today announced that health industry leader Kim Johnson has been appointed Global Chief Executive Officer [...]
Health Economics & Outcomes Research (HEOR) Services Market Leading Players Forecast …
The global Health Economics & Outcomes Research (HEOR) Services market highlights industry and market information, technologies, and dominant … Read [...]
PharmacoEconomics Article Highlights Rare Disease Therapeutics Tied to Patient Outcomes
A recent publication considers how treatments for rare diseases are priced according to patient outcomes. The study aims to compare [...]
Moderate Democrats Singled Out by Targeted Drug Pricing Ads
Ad campaigns supporting drug pricing reform are being launched in states with moderate Democrats who may vote against healthcare legislation [...]
Pfizer Heart Failure Medication Lawsuit Ruling Could Broadly Impact Medicare, Lead to Expensive Aduhelm Coverage
Pfizer is seeking legal backing for its plan to pay healthcare costs for Medicare patients taking one of its pricy [...]
PhRMA awards $75,000 to fund initiatives to reduce health inequities
As part of PhRMA’s continuing commitment to build a more just and equitable health care system, we recently awarded $75,000 [...]